Magnetic Insight develops imaging systems based on Magnetic Particle Imaging (MPI) to enable high-sensitivity visualization of biological processes. The company’s technology focuses on detecting magnetic nanoparticles with high temporal resolution and quantitative accuracy. Its platforms are designed to support advanced imaging applications beyond the capabilities of conventional MRI. Magnetic Insight positions its systems within preclinical research and emerging clinical imaging contexts.

The technology uses oscillating magnetic fields to directly image the spatial distribution of superparamagnetic nanoparticles. Unlike MRI, MPI produces signal only from the particles themselves, enabling high contrast and linear quantification without background tissue signal. This allows precise tracking of blood flow, perfusion, and cellular movement in real time. The systems are optimized for sensitivity and speed, supporting dynamic imaging applications.

Magnetic Insight targets preclinical research applications such as cardiovascular imaging, cancer research, and cell tracking, with ongoing efforts to translate MPI into clinical diagnostics. The technology is intended for use in research institutions and, over time, clinical environments. Its positioning reflects growing interest in novel imaging modalities that offer quantitative, high-speed alternatives to established techniques.